亚虹医药 (688176.sh)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(亚虹医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 24,319,537.4513,753,343.122,996,071.2577,772.9622,874.4026,095.3216,945.569,149.769,149.76
 营业利润(元) -83,313,061.22-404,003,134.48-267,129,827.43-185,906,801.46-62,934,818.04-247,553,098.25-163,964,189.51-89,772,309.38-47,294,447.61
 利润总额(元) -83,313,061.22-401,503,000.65-268,156,193.61-185,433,139.74-62,934,818.04-245,267,088.10-161,678,267.61-88,272,306.89-47,294,447.66
 净利润(元) -82,969,385.29-400,834,988.69-268,156,193.61-185,433,139.74-62,934,818.04-246,593,608.24-162,817,537.02-89,606,652.66-47,294,447.66
 归属于母公司股东的净利润(元) -82,848,207.86-400,434,603.65-268,043,612.10-185,433,139.74-62,934,818.04-246,593,608.24-162,817,537.02-89,606,652.66-47,294,447.66
盈利能力:
 销售毛利率(%) 78.9779.0082.8985.0089.8473.0266.5684.9984.99
 销售净利率(%) -341.16-2,914.45-8,950.26-238,428.81-275,132.10-944,972.54-960,827.13-979,333.37-516,892.77
 净资产收益率(%) -3.31-15.52-9.99-6.72-2.22----
 总资产报酬率ROA(%) -3.50-15.97-10.44-7.07-2.31----
 投入资本回报率ROIC(%) -3.39-15.26-10.04-6.89-2.29-8.51-5.54-3.01-1.58
营运能力:
 存货周转率(次) 1.841.310.180.000.00----
 应收账款周转率(次) 2.403.1636.261.631.05----
 总资产周转率(次) 0.010.000.00------
偿债能力:
 资产负债率(%) 10.089.216.513.783.453.583.362.932.15
 股东权益比率(%) 89.8690.7293.4296.2296.5596.4296.6497.0797.85
 已获利息倍数(倍) 8.7511.5011.1212.4014.9010.618.087.118.08
 流动比率 11.3512.8221.1229.4935.9034.2233.3739.5059.26
 速动比率 11.2312.6920.8729.1035.4833.8332.9939.0158.55
发展能力:
 营业收入增长率(%) 106,217.7152,604.2517,580.57750.00150.00470.40---
 营业利润增长率(%) -32.38-63.20-62.92-107.09-33.07-3.866.0930.1544.70
 税后利润增长率(%) -31.64-62.42-64.63-106.94-33.07-4.965.0628.6645.18
 净资产增长率(%) -15.27-13.82-11.76-11.20-8.53-8.03309.86294.17-
 总资产增长率(%) -8.96-8.41-8.72-10.41-7.29-7.26290.28279.61-

前瞻产业研究院